UBS Group’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-55,201
| Closed | -$3.98M | – | 9965 |
|
|
2020
Q4 | $3.98M | Buy |
55,201
+14,969
| +37% | +$784K | ﹤0.01% | 2698 |
|
|
2020
Q3 | $1.83M | Sell |
40,232
-40,196
| -50% | -$1.68M | ﹤0.01% | 3129 |
|
|
2020
Q2 | $3.63M | Sell |
80,428
-1,106
| -1% | -$49.6K | ﹤0.01% | 2319 |
|
|
2020
Q1 | $3.14M | Sell |
81,534
-48,742
| -37% | -$2.24M | ﹤0.01% | 2340 |
|
|
2019
Q4 | $6.03M | Buy |
130,276
+33,396
| +34% | +$1.45M | ﹤0.01% | 2436 |
|
|
2019
Q3 | $3.95M | Buy |
96,880
+18,007
| +23% | +$777K | ﹤0.01% | 2603 |
|
|
2019
Q2 | $3.8M | Buy |
78,873
+17,506
| +29% | +$920K | ﹤0.01% | 2558 |
|
|
2019
Q1 | $3.84M | Sell |
61,367
-11,302
| -16% | -$776K | ﹤0.01% | 2416 |
|
|
2018
Q4 | $4.34M | Buy |
72,669
+6,429
| +10% | +$386K | ﹤0.01% | 2277 |
|
|
2018
Q3 | $4.27M | Sell |
66,240
-13,197
| -17% | -$736K | ﹤0.01% | 2495 |
|
|
2018
Q2 | $3.57M | Sell |
79,437
-6,915
| -8% | -$276K | ﹤0.01% | 2632 |
|
|
2018
Q1 | $2.68M | Sell |
86,352
-2,390
| -3% | -$78.6K | ﹤0.01% | 2882 |
|
|
2017
Q4 | $2.65M | Sell |
88,742
-19,203
| -18% | -$556K | ﹤0.01% | 2945 |
|
|
2017
Q3 | $3.56M | Buy |
107,945
+23,677
| +28% | +$820K | ﹤0.01% | 2550 |
|
|
2017
Q2 | $2.82M | Sell |
84,268
-33,432
| -28% | -$997K | ﹤0.01% | 2684 |
|
|
2017
Q1 | $3.41M | Buy |
117,700
+33,184
| +39% | +$822K | ﹤0.01% | 2439 |
|
|
2016
Q4 | $1.89M | Buy |
84,516
+39,507
| +88% | +$772K | ﹤0.01% | 2959 |
|
|
2016
Q3 | $836K | Buy |
45,009
+597
| +1% | +$11.3K | ﹤0.01% | 3550 |
|
|
2016
Q2 | $724K | Sell |
44,412
-635
| -1% | -$9.34K | ﹤0.01% | 3626 |
|
|
2016
Q1 | $526K | Sell |
45,047
-1,203
| -3% | -$13.4K | ﹤0.01% | 3736 |
|
|
2015
Q4 | $540K | Sell |
46,250
-1,390
| -3% | -$17.6K | ﹤0.01% | 3883 |
|
|
2015
Q3 | $583K | Sell |
47,640
-5,936
| -11% | -$75.7K | ﹤0.01% | 3769 |
|
|
2015
Q2 | $505K | Sell |
53,576
-4,000
| -7% | -$37K | ﹤0.01% | 4113 |
|
|
2015
Q1 | $510K | Sell |
57,576
-8,955
| -13% | -$90.5K | ﹤0.01% | 4126 |
|
|
2014
Q4 | $668K | Buy |
+66,531
| New | +$571K | ﹤0.01% | 3931 |
|
Other funds holding BEAT
UBS Group's BEAT Position: Q1 2021 in Review
UBS Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 55,201 shares — an estimated $3.98M sold.
UBS Group first reported a position in BEAT in Q4 2014 and held it in 25 quarters. The position peaked at $6.03M in Q4 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- UBS Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- UBS Group sold 55,201 BioTelemetry, Inc. shares in Q1 2021, an estimated $3.98M.
- UBS Group first reported a position in BioTelemetry, Inc. in Q4 2014 and held it in 25 quarters.
- UBS Group's BioTelemetry, Inc. position peaked at $6.03M in Q4 2019.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.